Rituximab - 20mg/ml solution

Rituximab - 20mg/ml solution

Catalog Number:
L002233864BIO
Mfr. No.:
FR138503
Price:
Quantity:
Add to Cart:
    • Overview
      • Rituximab is a glycosylated monoclonal antibody that binds to the CD20 cell surface protein which is widely expressed on B-cells. Through the binding of rituximab’s Fc portion, the antibody-dependent cellular cytotoxicity pathway (ADCC) and the complement-dependent cytotoxicity (CDC) pathway are initiated, both leading to B-cell lysis (Chisari, 2021). In addition, direct apoptosis can be the result of the inhibition of various B-cell signalling pathways. Rituximab is used in targeted therapy for chronic lymphocytic leukaemia (CLL), non-Hodgkin lymphoma (NHL) and some non-cancer pathologies, such as, multiple sclerosis (Johnson, 2001).

        Please contact us at for specific academic pricing.

    • Properties
      • Categories
        Protein Interactions
        CAS Number
        174722-31-7
        Molecular Formula
        C6416H9874N1688O1987S44
        Note
        There is no hazardous surcharge associated with this product.
        There is no special packaging charge associated with this product.

        * For research use only. Not for human or veterinary use

Documents

Specification

Note: If you don't receive our verification email, do the following:

  • Confirm that you entered your email address correctly.
  • Check if the email is in your spam or junk folder.
  • Or you may contact us at .
Copyright © Amerigo Scientific. All rights reserved.